We see a future where "smart" microscopes spot critical events—like a virus infecting a cell or a tumor beginning to spread—in real time. By automating everything from sample scanning to insight generation, R&D teams gain a deeper understanding of the "vast worlds of the tiny" with a fraction of the effort. Ultimately, we want to democratize sophisticated imaging technology, so labs everywhere can unlock insights hidden in the microscopic realm.
The Future of Data-Driven Microscopy
Cytely is a Swedish DeepTech company pioneering data-driven, smart microscopy. Our mission is to make advanced imaging radically simpler and more insightful, so breakthroughs happen faster—and benefit everyone. While we focus on biotech and pharmaceutical R&D today, our technology ultimately serves any advanced research team seeking to unlock deeper insights from the microscopic realm.
Philip Nordenfelt
CEO
I believe Cytely ultimately will positively impact millions of lives down the line - thanks to the hard working scientists and professionals we have the privilege of serving daily.
Pontus Nordenfelt
CSO
The future innovations in biotech and life sciences we all hope for will depend on our ability to quickly generate significant insights from increasingly more complex data and instruments. Cytely is an important building block for that reality to become true
Johannes Kumra Ahnlide
CTO
I love the intersection between hard sciences, business and the craftsmanship of cutting-edge algorithms. Cytely keeps me both entertained and stimulated in all of those areas and more
Oscar André
CPO
The amount of pain that seems to be pretty much just accepted by almost everyone when dealing with software in the complex RnD space is simply staggering. I chose to not accept it and Cytely is the answer to that calling
Vision
Mission
We exist to remove the bottlenecks of traditional microscopy. Our data-driven platform is built for precision, speed, and reproducibility—capturing fleeting, rare, or complex phenomena without guesswork. We believe these benefits should flow to all types of researchers—especially those in biotech and pharma—and, by extension, everyone who gains from faster cures, better diagnostics, and groundbreaking discoveries.
Charter
We are building safe, reliable, and scalable smart microscopy for advanced R&D. We will also consider our mission fulfilled if our work catalyzes or supports others in achieving similar ends—lowering costs, boosting accessibility, and sparking new breakthroughs wherever precise, high-fidelity quantitative imaging is needed.
